Tissue preserving strategies have been used successfully in other solid organ cancers, such as breast cancer. So, this highly targeted, precise acoustic scalpel technology represents a natural transition from treatment targeting the entire prostate to focusing treatment on the cancer.
Published data suggests that focal therapy offers harm reduction, which can offer a new option in a spectrum of care to treat prostate cancer based on risk profile and the balance of clinical benefits and quality of life.
This phase II trial is studying high-intensity focused ultrasound in treating patients with localized prostate cancer. University College London Hospitals.
Independently facilitated by The Pelican Cancer Foundation.
Copyright © 2021 Focal Therapy User Group. All Rights Reserved.